Combined modality treatment of locally advanced breast cancer: Adjuvant combination chemotherapy with and without doxorubicin Journal Article


Authors: Casper, E. S.; Guidera, C. A.; Bosl, G. J.; Hakes, T. B.; Kaufman, R. J.; Shurgot, B.; Kinne, D. W.
Article Title: Combined modality treatment of locally advanced breast cancer: Adjuvant combination chemotherapy with and without doxorubicin
Abstract: Forty-one women with non-metastatic but locally advanced breast cancer were treated by modified radical or radical mastectomy, and were then randomized to receive one of two adjuvant chemotherapy regimens. Regimen A consisted of 6 months of cyclophosphamide, adriamycin, and fluorouracil (CAF) followed by 6 months of cyclophosphamide, methotrexate, fluorouracil, vincristine, and prednisone (CMFVP). Regimen B was 12 months of CMFVP. Patients were stratified for estrogen-receptor status, and all patients with a positive estrogen receptor value received tamoxifen 20 mg bid in addition to the chemotherapy. Eight of 21 patients radomized to Regimen A are alive and free of disease, whereas only 1 of 20 patients on Regimen B is well. A trend toward improved disease-free survival favoring Regimen A was observed (P = .05), although a significant difference in overall survival has not been demonstrated. Our findings support the continued study of adriamycin-containing regimens in the adjuvant setting and in combined modality therapy of locally advanced breast cancer. © 1987 Martinus Nijhoff Publishers.
Keywords: adult; cancer chemotherapy; clinical article; aged; middle aged; prednisone; doxorubicin; fluorouracil; cancer combination chemotherapy; combined modality therapy; methotrexate; metastasis; breast; antineoplastic combined chemotherapy protocols; cyclophosphamide; vincristine; breast neoplasms; adjuvant chemotherapy; tamoxifen; therapy; intravenous drug administration; humans; human; female; locally advanced breast cancer; caf; cmfvp
Journal Title: Breast Cancer Research and Treatment
Volume: 9
Issue: 1
ISSN: 0167-6806
Publisher: Springer  
Date Published: 1987-02-01
Start Page: 39
End Page: 44
Language: English
DOI: 10.1007/bf01806692
PUBMED: 3593990
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. George Bosl
    430 Bosl
  2. Ephraim S Casper
    108 Casper
  3. Thomas B Hakes
    115 Hakes
  4. Richard J Kaufman
    13 Kaufman
  5. David Kinne
    64 Kinne